✓
Open
7 Nov 2023
✓
Close
9 Nov 2023
3
Allotment
—
✓
Listing
Mon, Nov 20, 2023
Price Band
₹84 per share
Issue Size
12,91,200 shares (agg. up to ₹11 Cr)
Lot Size
1,600 Shares
Listing Date
Mon, Nov 20, 2023
Latest GMP
₹5
Est. Gain
5.95%
✦ AI Insight
GMP Trend
20-11-2023₹5Est. ₹89+5.95%
19-11-2023₹5Est. ₹89+5.95%
18-11-2023₹5Est. ₹89+5.95%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 46.66x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 17.06 | 16.71 | 13.02 | 9.48 |
| Total Income | 5.64 | 24.67 | 26.91 | 16.95 |
| Profit After Tax | 0.75 | 2.04 | 0.78 | 0.17 |
| NET Worth | 3.87 | 3.12 | 1.07 | 0.29 |
| Reserves and Surplus | 0.87 | 0.12 | 1.06 | 0.28 |
| Total Borrowing | 3.47 | 2.14 | 3.24 | 2.32 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Mono Pharmacare Ltd. | SME | ₹14.84 Cr | ₹28 | null | ₹30.45 | +8.75% | ₹10.75 (+0.00%) |
| Shelter Pharma Ltd. | SME | ₹16.03 Cr | ₹42 | 5.62 | ₹41.96 | -0.10% | ₹27.90 (+7.31%) |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹42.25 (-4.52%) |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹734.10 (-0.45%) |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹209.50 (+1.67%) |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹95.10 (-4.90%) |
| Blue Jet Healthcare Ltd. | Mainboard | ₹840.27 Cr | ₹346 | 37.49 | ₹413.40 | +19.48% | ₹584.55 (-0.65%) |
| Valiant Laboratories Ltd. | Mainboard | ₹152.46 Cr | ₹140 | 15.71 | ₹170.25 | +21.61% | ₹63.44 (-2.55%) |
| Concord Biotech Ltd. | Mainboard | ₹1,550.52 Cr | ₹741 | 32.29 | ₹942.80 | +27.23% | ₹1,342.80 (-0.37%) |
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,484.20 (-2.10%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Meeting Working Capital Requirements | 8.55 |
| 2 | General Corporate Purpose | 1.40 |
About Sunrest Lifescience IPO
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products. The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory. The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh. Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc. With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.+ Rea
Contact Details
Sunrest Lifescience Ltd. AddressFF-41, Ajay Tenament-6Near Canal Near RitanagarBus Stand Vastral RoadAhmedabad, Gujarat, 382415+91-079 - 29918245info@sunrestlifescience.comVisit Website